 Analgesics
|
|
Anesthetics
|
|
Anti-Addiction/Substance Abuse Treatment Agents
|
|
Antibacterials
|
|
Anticonvulsants
|
|
Antidementia Agents
|
|
Antidepressants
|
|
Antiemetics
|
|
Antifungals
|
|
Antigout Agents
|
|
Anti-inflammatory Agents
|
|
Antimigraine Agents
|
|
Antimyasthenic Agents
|
|
Antimycobacterials
|
|
Antineoplastics
|
|
Antiparasitics
|
|
Antiparkinson Agents
|
|
Antipsychotics
|
|
Antispasticity Agents
|
|
Antivirals
|
|
Anxiolytics
|
|
Bipolar Agents
|
|
Blood Glucose Regulators
|
|
Blood Products/Modifiers/Volume Expanders
|
|
Cardiovascular Agents
|
|
Central Nervous System Agents
|
|
Dental and Oral Agents
|
|
Dermatological Agents
|
|
Electrolytes/Minerals/Metals/Vitamins
|
|
Gastrointestinal Agents
|
|
Genetic or Enzyme Disorder: Replacement, Modifiers, Treatment
|
|
 Genitourinary Agents
|
Antispasmodics, Urinary
|
Mirabegron
|
Darifenacin [DG:DG00482]
|
Fesoterodine [DG:DG00483]
|
Flavoxate [DG:DG00477]
|
 D07961 Flavoxate (INN)
D00718 Flavoxate hydrochloride (JP17/USAN)
|
Oxybutynin [DG:DG00478]
|
Solifenacin [DG:DG00481]
|
Tolterodine [DG:DG00480]
|
Trospium
|
Benign Prostatic Hypertrophy Agents
|
Genitourinary Agents, Other
|
|
Hormonal Agents, Stimulant/Replacement/Modifying (Adrenal)
|
|
Hormonal Agents, Stimulant/Replacement/Modifying (Pituitary)
|
|
Hormonal Agents, Stimulant/Replacement/Modifying (Prostaglandins)
|
|
Hormonal Agents, Stimulant/Replacement/Modifying (Sex Hormones/Modifiers)
|
|
Hormonal Agents, Stimulant/Replacement/Modifying (Thyroid)
|
|
Hormonal Agents, Suppressant (Adrenal)
|
|
Hormonal Agents, Suppressant (Pituitary)
|
|
Hormonal Agents, Suppressant (Thyroid)
|
|
Immunological Agents
|
|
Inflammatory Bowel Disease Agents
|
|
Metabolic Bone Disease Agents
|
|
Ophthalmic Agents
|
|
Otic Agents
|
|
Respiratory Tract/Pulmonary Agents
|
|
Skeletal Muscle Relaxants
|
|
Sleep Disorder Agents
|
USP Drug Classification